These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6316026)

  • 1. Pathogenesis of vaccinia (IHD-T) virus infection in BALB/cAnN mice.
    Jacoby RO; Bhatt PN; Johnson EA; Paturzo FX
    Lab Anim Sci; 1983 Oct; 33(5):435-41. PubMed ID: 6316026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexamination of the efficacy of vaccination against mousepox.
    Buller RM; Wallace GD
    Lab Anim Sci; 1985 Oct; 35(5):473-6. PubMed ID: 2997541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vaccination on the clinical response, pathogenesis and transmission of mousepox.
    Bhatt PN; Jacoby RO
    Lab Anim Sci; 1987 Oct; 37(5):610-4. PubMed ID: 2826878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
    Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
    Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
    Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aerosol vaccination against mousepox (infectious ectromelia) in comparison with other vaccination methods using vaccinia and mousepox vaccines].
    Munz E; Reimann M; Zschekel WD
    Zentralbl Veterinarmed B; 1976 Jun; 23(5-6):431-46. PubMed ID: 183420
    [No Abstract]   [Full Text] [Related]  

  • 7. The antigenicity and immunogenicity of the intracellular and extracellular forms of vaccinia virus. I: The production of high-titre vaccinia extracellular virus and its antigenicity after inactivation.
    Thornton B
    Br J Exp Pathol; 1980 Aug; 61(4):444-50. PubMed ID: 7426394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis.
    Jacoby RO; Bhatt PN
    Lab Anim Sci; 1987 Feb; 37(1):16-22. PubMed ID: 3035274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
    Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
    J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
    Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
    J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
    Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
    Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.
    Villacres MC; Zuo J; Bergmann CC
    Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
    Gurt I; Abdalrhman I; Katz E
    Antiviral Res; 2006 Mar; 69(3):158-64. PubMed ID: 16406098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH; Wang TL; Ji H; Hung CF; Pardoll DM; Cheng WF; Ling M; Wu TC
    Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and the immunogenicity of the recombinant Modified Vaccinia Virus Ankala co-expressing ORF4, ORF5 and ORF6 genes of porcine reproductive and Respiratory Syndrome Virus NJ-a strain].
    Zheng QS; Bi ZX; Li P; Chen DS; Chen PY
    Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):345-9. PubMed ID: 17552247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intradermal model for vaccinia virus pathogenesis in mice.
    Lin LC; Smith SA; Tscharke DC
    Methods Mol Biol; 2012; 890():147-59. PubMed ID: 22688766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.